May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Further Characterization of Keratocan Promoter
Author Affiliations & Notes
  • W.–L. Chen
    Ophthalmology, University of Cincinnati, Cincinnati, OH
  • C.–Y. Liu
    Ophthalmology, University of Miami, Miami, FL
  • Y. Hayashi
    Ophthalmology, University of Cincinnati, Cincinnati, OH
  • T.–I. Chikama
    Ophthalmology, University of Cincinnati, Cincinnati, OH
  • W.W. Kao
    Ophthalmology, University of Cincinnati, Cincinnati, OH
  • Footnotes
    Commercial Relationships  W. Chen, None; C. Liu, None; Y. Hayashi, None; T. Chikama, None; W.W. Kao, None.
  • Footnotes
    Support  Support NIH grant EY11845, EY12486, RPB, OLERF
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3778. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W.–L. Chen, C.–Y. Liu, Y. Hayashi, T.–I. Chikama, W.W. Kao; Further Characterization of Keratocan Promoter . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3778.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: It has been previously demonstrated that a 3.2 kb DNA fragment up–stream of keratocan gene (Kera) has the promoter activities for the tissue specific expression of reporter genes similar to the expression pattern of Kera (Liu et al, Gene, 250: 85–96, 2000). The purpose of present study was to identify the cis–regulatory DNA elements modulating Kera expression. Methods: Deletion mutant reporter genes containing 0.3, 1.5, 2.6 kb DNA fragments 5’ to Kera gene were prepared from the Kerapr–3.2kb–ßGeo minigene. The functionality of the reporter minigenes were determined by measuring ß–galactosidase (ß–gal) activities in tissues of transgenic mice produced by microinjection, and the injection of minigenes into corneal stroma and skeletal muscles of wild type mice. Results: Only transgenic mice carrying the 3.2 kb Kera promoter exhibited ß–gal activity in a pattern similar to what was previously reported, except the enzyme activity were also detected in lacrimal and Meibomian glands of P0 (new born) mice. The reporter genes containing 1.5 and 2.6 kb 5’–Kera DNA fragments failed to express the ß–gal activity in any tissues of the transgenic mice. Use of intrastromal injection of the minigenes revealed that the 3.2 kb has highest ß–gal activity, the other reporter genes produced much less enzyme activity. Conclusions: The 3.2kb Kera promoter contains sufficient cis–regulatory elements for the reporter gene expression in cells expressing keratocan. The identification of ß–gal expression by the mesenchymal cells of lacrimal and Meibomian glands suggests that these cells are of neural crest origin.

Keywords: cornea: stroma and keratocytes • gene/expression • gene transfer/gene therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×